SEC Comment Letter for PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — May 18, 2018
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: May 18, 2018 · CIK: 0001095981 · Accession: 0000000000-18-015524
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3030 May 1 8, 2018 Via E -mail Marc H. Hedrick, MD President and Chief Executive Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, CA 92121
Re: Cytori Therapeutics, Inc. Registration Statement on Form S-1 Filed April 27, 2018 File No. 333 -224502
Dear Dr. Hedrick :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Show Raw Text
Mail Stop 3030
May 1 8, 2018
Via E -mail
Marc H. Hedrick, MD
President and Chief Executive Officer
Cytori Therapeutics, Inc.
3020 Callan Road
San Diego, CA 92121
Re: Cytori Therapeutics, Inc.
Registration Statement on Form S-1
Filed April 27, 2018
File No. 333 -224502
Dear Dr. Hedrick :
This is to advise you that we have not reviewed and will not review your registration
statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Amanda Ravitz
Assistant Director
Office of Electronics and Machinery
cc: Chest on J. Larson, Esq.